Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Larix occidentalis pollen is an allergenic extract derived from the pollen of the Western Larch tree, a deciduous conifer native to the Pacific Northwest. It is primarily utilized as a diagnostic tool in in-vivo allergy testing, such as skin prick tests or intradermal tests, to identify hypersensitivity in patients suspected of having respiratory allergies to this specific tree species. As an allergen product, it works by eliciting a localized IgE-mediated allergic response in sensitized individuals, resulting in a visible wheal-and-flare reaction that confirms clinical sensitivity. The product is classified as a biological extract and is regulated as an allergenic product rather than a therapeutic drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on larix occidentalis pollen.